229 related articles for article (PubMed ID: 7274948)
1. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
Haas S; Ketterl R; Blümel G
Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
[TBL] [Abstract][Full Text] [Related]
2. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Arfors KE; Bergqvist D; Tangen O
Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
4. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Baumgartner HR
Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone].
Gastpar H
Fortschr Med; 1978 Sep; 96(36):1823-7. PubMed ID: 700559
[TBL] [Abstract][Full Text] [Related]
6. Platelet survival and adhesiveness in recurrent venous thrombosis.
Steele PP; Weily HS; Genton E
N Engl J Med; 1973 May; 288(22):1148-52. PubMed ID: 4699744
[No Abstract] [Full Text] [Related]
7. Effect of etofylline clofibrate on experimental thrombosis and platelet function.
Sim AK; Davies ME; McCraw AP; Metz G
Arzneimittelforschung; 1980; 30(11b):2042-5. PubMed ID: 7194057
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
Renaud S; Lecompte F
Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948
[No Abstract] [Full Text] [Related]
9. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
10. The role of platelets in thrombotic and vascular disease.
Schafer AI; Handin RI
Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914
[No Abstract] [Full Text] [Related]
11. [Anti-platelet aggregation therapy in vascular microsurgery: experimental study with sulfinpyrazone].
Gaspari A; Ortensi A; Lania M; Ipri D; Busatta D
Ann Ital Chir; 1983; 55(1):89-94. PubMed ID: 6651058
[No Abstract] [Full Text] [Related]
12. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
13. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
[No Abstract] [Full Text] [Related]
14. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
15. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
[TBL] [Abstract][Full Text] [Related]
16. Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study.
Sharma HM; Moore S; Merrick HW; Smith MR
Am J Pathol; 1972 Mar; 66(3):445-60. PubMed ID: 4551295
[TBL] [Abstract][Full Text] [Related]
17. Platelet and antiplatelet agents in strokes.
Rodvien R; Mielke CH
Stroke; 1978; 9(4):403-5. PubMed ID: 675751
[No Abstract] [Full Text] [Related]
18. Sulfinpyrazone and platelet function in hypertensive patients.
Davi G; Novo S; Gullotti D; Avellone G; Sofia MA; Strano A
Thromb Haemost; 1984 Jul; 51(3):413. PubMed ID: 6388015
[No Abstract] [Full Text] [Related]
19. Treatment with sulfinpyrazone of essential mixed cryoglobulinemia.
Boschetti C; Cortellaro M; Invernizzi F; Massaro P; Rigolone A; Polli E
Boll Ist Sieroter Milan; 1985; 64(1):55-8. PubMed ID: 3159402
[TBL] [Abstract][Full Text] [Related]
20. Prevention of experimental carotid artery thrombosis by applaggin.
Rote WE; Mu DX; Roncinske RA; Frelinger AL; Lucchesi BR
J Pharmacol Exp Ther; 1993 Nov; 267(2):809-14. PubMed ID: 8246155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
